LATEST UPDATES » Vol 23, No 04, April 2019 – Career development for researchers       » CRISPR not as precise as thought       » Insomnia spreads among young Chinese       » Chinese HEV vaccine begin clinical trial in U.S       » Eating mushrooms may reduce risk of cognitive decline       » Green tea cuts obesity in mice      
Philips and Singapore Institute of Advanced Medicine Holdings open regional oncology center
First phase of Singapore’s Advanced Medicine Imaging Center provides accurate and timely diagnosis of cancer, plus an education center for medical training and scientific research collaborations. New treatment innovations, including radioisotope and proton beam therapies, will be made progressively available

Royal Philips, a global company in health technology, and the Singapore Institute of Advanced Medicine Holdings (SAM) have opened the Advanced Medicine Imaging (AMI) center at Biopolis, an international biomedical research hub in Singapore.

The new SGD100 million facility will provide specialized oncology care to the fast-growing number of people confronted with cancer in Southeast Asia. In addition, the center will facilitate scientific research and development and provide medical training targeted at upskilling the region’s healthcare professionals in the newest cancer therapies.

The AMI center is equipped with advanced imaging systems and clinical informatics aimed at helping clinicians deliver confident diagnosis of cancer with increased speed and efficiency. The facilities, which will open in phases, are scheduled for completion by the end of 2019.

It will house two Philips Vereos PET/CT scanners, the world’s first and only fully digital PET/CT systems. Using proprietary Digital Photon Counting (DPC) technology, Philips’ Vereos PET/CT provides outstanding anatomical imaging and enhances lesion detectability with improved contrast and resolution.

Another world-first solution at AMI is Philips’ IQon Spectral CT, a new generation Computed Tomography (CT) solution that allows clinicians to characterize tumors with greater certainty than is possible with black and white images from conventional CT scans. Philips’ IQon Spectral CT is also the world's first spectral detector-based CT that allows clinicians to do both in-depth spectral information on demand and retrospective analysis at low-dose – a direct benefit to patients.

The regional oncology center also aims to promote clinical research for breakthroughs in cancer diagnostics and treatment, and cross-border medical training to enhance the knowledge and expertise of the region’s healthcare professionals.

Click here for the complete issue.

news Which country has the worst sleepers
news Asia is the fastest growing region for nutraceuticals
news 2018 Nobel Prize in Physiology or Medicine winners
news Vitafoods Asia expands by 40 per cent in 2018
Asia Pacific Biotech News

APBN Editorial Calendar 2019
Taiwan Medical tourism
Marijuana as medicine — Legal marijuana will open up scientific research
Driven by curiosity
Career developments for researchers
Editorial calendar is subjected to changes.
About Us
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
Copyright© 2019 World Scientific Publishing Co Pte Ltd  •  Privacy Policy